Pros
Get to learn how to run a company to the bottom
Cons
They acquired Shire out of fear that pipeline has drained and soon investors will find out, and CXOs can no longer cash in tens of millions dollars annually. So they made the decision to swallow an elephant, let go thousands of hardworking employees who have a family to feed. There’s no innovation of kind involved, anyone with elementary level education can get it the maths to work - merge two large systems, lay off tons, streamline operations, and you get beautiful top and bottom numbers out of the power of synergy! It’s just a financial trick to get by for another 3-5 years but not sustainable for the long run, no innovation or vision required. True innovative pharmaceutical invest in their people and technology, acquire solid assets, build deep pipeline, and celebrated/share its success with people, this company does everything opposite.